価格表
在庫・価格 : 2025年10月08日 10時44分 現在
商品名 | 商品コード | メーカー | 包装 | 価格 | 在庫 | リスト |
---|---|---|---|---|---|---|
Anti-Rat VEGF 164 Affinity Purified Polyclonal Ab データシート※最新のデータシートでない場合があります |
AF564-SP |
RSDアールアンドディー システムズ R&D Systems, Inc. |
25 μg | ¥28,000 |
無 (未発注) |
追加 |
在庫・価格 : 2025年10月08日 10時44分 現在
Anti-Rat VEGF 164 Affinity Purified Polyclonal Ab
- 商品コード:AF564-SP
- メーカー:RSD
- 包装:25μg
- 価格: ¥28,000
- 在庫:無(未発注)
使用文献
- No.: 1
-
文献情報:
Khalili S et al. The effect of a single anti-Vascular Endothelial Growth Factor injection on neonatal growth and organ development: In-vivo study. Exp Eye Res 2018 04;169:54-59
Khalili S et al
2018/01/01
-
備考:
Species: Rat, Applications: In Vivo -
参照:
- No.: 2
-
文献情報:
Asano D et al. Cellular Mechanisms of Angiogenesis in Neonatal Rat Models of Retinal Neurodegeneration. Int J Mol Sci 2019 Sep;20(19)
Asano D et al
2019/01/01
-
備考:
Species: Rat, Applications: ICC -
参照:
- No.: 3
-
文献情報:
Advani A et al. Role of VEGF in maintaining renal structure and function under normotensive and hypertensive conditions. Proc. Natl. Acad. Sci. U.S.A. 2007 Sep;104(36):14448-53
Advani A et al
2007/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 4
-
文献情報:
Wang H et al. Quantitative analyses of retinal vascular area and density after different methods to reduce VEGF in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2014 Feb;55(2):737-44
Wang H et al
2014/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 5
-
文献情報:
Hartnett ME et al. Neutralizing VEGF decreases tortuosity and alters endothelial cell division orientation in arterioles and veins in a rat model of ROP: relevance to plus disease. Invest. Ophthalmol. Vis. Sci. 2008 Jul;49(7):3107-14
Hartnett ME et al
2008/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 6
-
文献情報:
Baron-Menguy C et al. Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J. 2007 Nov;21(13):3511-21
Baron-Menguy C et al
2007/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 7
-
文献情報:
McCloskey M et al. Anti-VEGF antibody leads to later atypical intravitreous neovascularization and activation of angiogenic pathways in a rat model of retinopathy of prematurity. Invest. Ophthalmol. Vis. Sci. 2013 Mar;54(3):2020-6
McCloskey M et al
2013/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 8
-
文献情報:
Melly L et al. Myocardial infarction stabilization by cell-based expression of controlled Vascular Endothelial Growth Factor levels. J. Cell. Mol. Med. 2018 May;22(5):2580-2591
Melly L et al
2018/01/01
-
備考:
Species: Rat, Applications: IHC -
参照:
- No.: 9
-
文献情報:
Imberti B et al. Renal primordia activate kidney regenerative events in a rat model of progressive renal disease. PLoS ONE 2015;10(3):e0120235
Imberti B et al
2015/01/01
-
備考:
Species: Rat, Applications: IHC -
参照:
- No.: 10
-
文献情報:
Shimojo N et al. Contributory role of VEGF overexpression in endothelin-1-induced cardiomyocyte hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 2007 Jul;293(1):H474-81
Shimojo N et al
2007/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 11
-
文献情報:
Deliyanti D et al. FT011, a Novel Cardiorenal Protective Drug, Reduces Inflammation, Gliosis and Vascular Injury in Rats with Diabetic Retinopathy. PLoS ONE 2015;10(7):e0134392
Deliyanti D et al
2015/01/01
-
備考:
Species: Rat, Applications: IHC-P -
参照:
- No.: 12
-
文献情報:
Mirabelli P et al. Genome-wide expression differences in anti-Vegf and dexamethasone treatment of inflammatory angiogenesis in the rat cornea. Sci Rep 2017 Aug;7(1):7616
Mirabelli P et al
2017/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 13
-
文献情報:
Yeh WL et al. Inhibition of hypoxia-induced increase of blood-brain barrier permeability by YC-1 through the antagonism of HIF-1alpha accumulation and VEGF expression. Mol. Pharmacol. 2007 Aug;72(2):440-9
Yeh WL et al
2007/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 14
-
文献情報:
Lind T et al. Bones in human CYP26B1 deficiency and rats with hypervitaminosis A phenocopy <i>Vegfa</i> overexpression. Bone Rep 2018 Dec;9:27-36
Lind T et al
2018/01/01
-
備考:
Species: Rat, Applications: IHC -
参照:
- No.: 15
-
文献情報:
Yeh WL et al. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. Mol. Pharmacol. 2008 Jan;73(1):170-7
Yeh WL et al
2008/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 16
-
文献情報:
Daniel C et al. Long-term gene therapy with thrombospondin 2 inhibits TGF-β activation, inflammation and angiogenesis in chronic allograft nephropathy. PLoS ONE 2013;8(12):e83846
Daniel C et al
2013/01/01
-
備考:
Species: Rat, Applications: IHC -
参照:
- No.: 17
-
文献情報:
Irani Y et al. Production of scFv antibody fragments from a hybridoma with functional activity against human vascular endothelial growth factor. Hybridoma (Larchmt) 2009 Jun;28(3):205-9
Irani Y et al
2009/01/01
-
備考:
Species: Human, Applications: Binding Assay -
参照:
- No.: 18
-
文献情報:
Westenbrink BD et al. Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure. Cardiovasc. Res. 2010 Jul;87(1):30-9
Westenbrink BD et al
2010/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照:
- No.: 19
-
文献情報:
Lin HH et al. Heme oxygenase-1 promotes neovascularization in ischemic heart by coinduction of VEGF and SDF-1. J. Mol. Cell. Cardiol. 2008 Jul;45(1):44-55
Lin HH et al
2008/01/01
-
備考:
Species: Mouse, Applications: Neutralization -
参照:
- No.: 20
-
文献情報:
Dharmani P et al. The probiotic mixture VSL#3 accelerates gastric ulcer healing by stimulating vascular endothelial growth factor. PLoS ONE 2013;8(3):e58671
Dharmani P et al
2013/01/01
-
備考:
Species: Rat, Applications: Neutralization -
参照: